Schedule 13G ownership disclosure

Puma Biotechnology Inc

Security class unavailable · CUSIP: 74587V107

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,355,643
Percent of class
11.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-18-000004
Form type
SC 13G
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Jan 10, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub